The Institute for Safe Medication Practices added tranexamic acid injection solutions to its high-alert medications list, which registers drugs linked with a high risk of causing significant harm to patients if used in error.
As the FDA imports a syphilis drug from France that's been in short supply since spring 2023, the FDA and American Society of Health-System Pharmacists have reported five new drug supply issues in 2024.
Popular medications indicated for Type 2 diabetes or chronic weight management, including Ozempic, Mounjaro and Wegovy, are dancing through a flood of research for broader indications.
On Jan. 11, the FDA said it has not found a causal link between glucagon-like peptide-1 receptor agonists, such as Ozempic and Mounjaro, and suicidal thoughts.
Even after the FDA issued a warning in 2020 about the adverse effects linked to Singulair, a now generic asthma drug, and strengthened its warning in 2022, physicians continue to prescribe it to millions of patients.
A 6-year-old patient received three extra doses of two chemotherapies in late 2022, and the FDA sent Children's Hospital of Michigan a warning letter about the mistake.
Experts and industry analysts largely agree Eli Lilly's new direct-to-consumer platform will increase access to patients who may benefit from its new anti-obesity drug Zepbound, but questions are being raised surrounding appropriate care coordination and the business model behind the…
Ozempic and other glucagon-like peptide-1 receptor agonists are not linked to a higher risk of pancreatic cancer compared to insulin, according to a recent study.
